Singapore develops microdroplets to reduce colorectal tumour growth at potentially lower cost

Scientists from Nanyang Technological University (NTU), Singapore have developed microscopic peptide droplets that deliv...

September 4, 2026 | Friday | News
Two Days That Mapped the Next Phase of APAC Dealmaking

EVENT WRAP-UP | ASIA BIO PARTNERING FORUM 2026 A forum that met the moment Some conferences describe the industry. The...

September 2, 2026 | Wednesday | News
Most Assets Die on Fit, Not on Data

"Almost every company preparing for a partnering conversation prepares for the wrong gate. The rejection usually happens...

September 2, 2026 | Wednesday | News
Bridges Are Not Symmetrical: Reading the Asia Bio Cross-Border Keynote

Cross-border partnership is usually discussed as two parties meeting in the middle. The more accurate picture is a struc...

September 2, 2026 | Wednesday | News
Singapore expands subsidised access to Roche’s Columvi for relapsed or refractory DLBCL

Singapore is expanding subsidised access to Roche’s Columvi, or glofitamab, for eligible patients with relapsed or...

September 2, 2026 | Wednesday | News
Singapore becomes first ASEAN market to subsidise vutrisiran for transthyretin amyloidosis

Singapore has become the first ASEAN country to provide government subsidies for eligible patients receiving vutrisiran ...

September 2, 2026 | Wednesday | News
Five Allocators, No Founders: What the Asia Bio Dealmaking Panel Was Really Pricing

A session billed as a conversation about partnering was, on closer inspection, something rather more useful: a pricing s...

September 1, 2026 | Tuesday | News
The New APAC Healthcare Equation: Innovation, Capital, AI and Global Scale

The most useful thing about an opening plenary is usually not what gets said. It is who the organisers decided to put on...

September 1, 2026 | Tuesday | News
DIPG Alliance to raise S$5 M over five years to establish Singapore's first enduring paediatric brain tumour research fund

DIPG Alliance, Singapore's first charitable foundation dedicated to advancing research for Diffuse Intrinsic Pontine Gli...

September 2, 2026 | Wednesday | News
Singapore makes effort to close invisible gap in inflammatory bowel disease

Inflammatory bowel disease (IBD) can be deceptive. Over time, this unseen inflammation can damage the intestinal lining ...

August 28, 2026 | Friday | News
“Our long-term vision is to establish Singapore as a worldwide hub for allogeneic cell therapy”

How will the new investment accelerate the development of TAVST01? When do you plan to launch the product in the market?...

September 1, 2026 | Tuesday | Opinion
Singapore's MuseCell Innovations announces manufacturing collaboration with Celularity in US

US-based Celularity Inc., a longevity-focused regenerative and cellular medicine company, and Singaporean startup M...

August 27, 2026 | Thursday | News
Singapore designs bioinspired nanoparticles that deliver gene editing to lower bad cholesterol

Researchers from the National University of Singapore (NUS) Medicine and China's Tianjin Medical University General Hosp...

August 26, 2026 | Wednesday | News
Engineering the Future of Healthcare with Artificial Intelligence: Taiwan to lead the Forefront in Asia

As healthcare systems across Southeast Asia embrace smarter technologies and new models of care, Taiwan is looking to de...

August 24, 2026 | Monday | News
A*STAR study links autism diversity to spatial changes in developing brain

Researchers from A*STAR have identified spatial differences in early brain development that could help explain why autis...

August 18, 2026 | Tuesday | News
Singapore tackles healthcare challenges with interdisciplinary approach

Nanyang Technological University (NTU), OUE Limited and its healthcare subsidiary, OUE Healthcare, have announced a set ...

August 18, 2026 | Tuesday | News
Singapore approves GSK's Blenrep combinations for treatment of relapsed/refractory multiple myeloma

GSK Singapore has announced that the Singapore Health Sciences Authority (HSA) has approved Blenrep for the treatment of...

August 19, 2026 | Wednesday | News
DayOne launches Singapore's first biological data centre prototype with Cortical Labs and NUS Medicine

DayOne Data Centers, a Singapore-headquartered global digital infrastructure platform, has launched Singapore's first Bi...

August 17, 2026 | Monday | News
Nominations Open for the BioSpectrum Asia Excellence Awards 2026

BioSpectrum Asia opened nominations for the BioSpectrum Asia Excellence Awards 2026, the 20th anniversary edition of the...

August 17, 2026 | Monday | News
Menarini Asia-Pacific’s Glen Godresse on reshaping biopharma commercialisation across Asia

Asia-Pacific is moving from being viewed primarily as a later-stage commercial market to becoming a more important sourc...

August 17, 2026 | Monday | Opinion
IASO Biotechnology acquires Singapore cell therapy company MediSix Therapeutics

IASO Biotechnology has completed its acquisition of Singapore-based MediSix Therapeutics, expanding its international ce...

August 14, 2026 | Friday | News
Singapore's K2 Therapeutics appoints new CEO and announces $50 M Seed Financing

Singapore-based biotech startup K2 Therapeutics has announced the appointment of Dr Ying Huang as Chief Executive Office...

August 14, 2026 | Friday | News
L'Oréal and NUS Medicine launch joint laboratory for healthy longevity research

Global beauty leader L'Oréal Groupe and the NUS Academy for Healthy Longevity at the Yong Loo Lin School of Medic...

August 12, 2026 | Wednesday | News
Merck expands biosafety testing laboratory in Singapore

Merck, a leading science and technology company, is expanding its Singapore lab to further strengthen analytical and bio...

August 11, 2026 | Tuesday | News
Medical Fair Asia 2026 brings Asia’s healthcare ecosystem together in Singapore

From medical manufacturing and AI-enabled healthcare to rehabilitation, assistive technology and independent living, the...

August 10, 2026 | Monday | News